“The acquisition of FGL enables NEB to combine our expertise in enzyme manufacturing and assay development with their expertise in lyophilization, providing a complete solution for our customers,” says Jim Ellard, CEO of New England Biolabs.
Read More
The review shows that rapid antigen tests are better at correctly identifying cases of COVID-19 in people with symptoms than in people without symptoms.
Read More
South Korea-based Soulbrain Holdings has acquired all controlling PixCell shares, making Soulbrain the majority shareholder of PixCell Medical.
Read More
Sense Biodetection has raised a $50 million Series B investment to advance commercialization of its Veros covid-19 product and continue development of a portfolio of instrument-free, rapid molecular tests.
Read More
NIH announced three new contracts and one new award to an existing contract for scale-up and manufacturing of novel covid-19 testing technologies.
Read More